Summary An increasing number of reports highlight the fact that tumour cells are able to give rise in vitro to immunogenic variants, which are defined in vivo as being non tumorigenic, tum-. We have observed the emergence of immunogenic variants, derived from a primary nickel-induced rat rhabdomyosarcoma established in culture (RMS 9-4/0), resistant to treatment with the chloronitrosourea, chlorozotocin (CZT) (Rlines). They were separated from the whole population of cells by a cloning procedure. Furthermore, we demonstrate that the cloning procedure by itself allows the isolation of tum-variant designated as C-lines. In both cases, the tum-phenotype was observed after s.c. injection of cells into syngeneic rats with a broad range of R9 or C8 cells (104 to 107). This characteristic was inherited in a stable manner. Athymic mice developed tumours of rat rhabdomyosarcoma origin when grafted with 105 cells. Immunization of rats with one R variant (R9) tum-protected the rats grafted with the parental RMS 9-4/0 cells against metastatic invasion of the lungs, but not against local tumour growth, and rats grafted with a CZT-resistant tum+ cell variant S4T (in vivo-derived) against its hepatic and pulmonary metastases, while the local tumour progressed as usual. Immunization of rats with one C variant (C8) tum-cells did not protect them against either metastases or local growth of the implanted tumours. Both R and C lines cells became progressively resistant to NK-and macrophage-induced cytotoxicity. Splenic lymphocyte transfer from immune rats into nude mice, i.e., the Winn test, showed a complete degree of protection against C8 or R9 tumour growth.
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We conclude that two different antigenicities were revealed, one common to R9 and C8 cells in relation with their selection procedure by repeated cloning. Another antigenicity appeared in the R9 line, selected by CZT-resistance. The anti R9 cell immunization against CZT-resistant tum+ S4T could argue in favour of CZT action in the acquisition of R9 cell antigenicity. More likely, an amplification of antigens rather than induction of a new antigen could explain the protection of anti R9 immunized rats against parental tumour metastases.
Induction of tumour cell antigenicity as a consequence of been demonstrated, see e.g. Evans, 1986) or if the tumour their treatment by drugs has already been demonstrated by cells present the epitopes in an inefficient way to the immune several authors (Fioretti et al., 1983; Nardelli et al., 1984;  system (loss of expression of major histocompatibility Boon & Kellerman, 1977) . Circumstances under which such complex antigens, for example). observations have been made differed. For example, Van Pel More and more authors have reported that tumour cells and Boon, (1983) showed that MNNG and other mutagenic are able to give rise to new variants, especially nondrugs were able to induce in tumour cells a high level of tumorigenic variants, obviously obtained in vitro in the variants able to protect mice against primary leukaemia.
absence of the immune pressure exerted in vivo by the host, Interestingly, they demonstrated that some of them were not as reported by Price (Price et al., 1986) . Spontaneous or tumorigenic when reinjected into syngeneic animals, thus drug-induced mutations could be responsible for this effect. defining the term tum- (Boon, 1985) . Injected into Technically, the cloning procedure preceding the selection of immunoincompetent animals, the same cells were the sublines is absolutely necessary, in order to demonstrate tumorigenic, indicating that the lack of tumorigenicity in the emergence of these immunogenic variants. Without normal animals was due to the immunological rejection of cloning, the immunogenic variants are diluted in a broad the variants. In their subsequent papers, Boon et al. ( (Chen, 1977) .
free FCS (from Flow Laboratories, UK), counted and Chlorozotocin-resistant variants were selected from the distributed into the wells of microplates at concentrations of RMS 9-4/0 parental line by repeated exposure to CZT using 1.25, 2.5, 5 and 10 x 104 cells per well in 0.1 ml of 5% the following procedure. Cells in log-phase growth monoendofree FCS-HAM medium. layers were detached by a 0.25% trypsin/PBS solution, put Tumour cells were pre-labelled with [14C]-inosine (specific into tubes in the presence of serum, washed once, adjusted activity 40-60 mCi mmol-1; Amersham, UK). Briefly, 1 x 106 to 106ml -1, exposed to 0.4,g ml-I of just thawed CZT, and cells were seeded in a 10cm Falcon petri dish in 10ml of kept at 37°C for 1 h. Then, treated cells were washed twice, standard culture medium; 0.1 I Ci of [I4C]-inosine was added suspended in 0.3% Bacto-agar (Difco Lab, Detroit, MI), to the medium and the mixture was incubated overnight in kept fluid at 37°C in a water bath, then deposited onto a a 5% C02/air incubator at 37°C. Labelled tumour cell gelled 0.6% agar layer, previously prepared. After 1 week of monolayers were extensively washed with PBS, trypsinized, incubation at 37°C in a humidified atmosphere of 5% CO2 suspended in 5% endofree FCS-HAM medium, counted and in air, colonies of resistant cells were harvested with a adjusted to a concentration of 1 x 105 cellsml-1. This syringe under a microscope and each colony was seeded in suspension (0.1 ml) was added to each well. To activate a 35mm Falcon petri dish according to the liquid medium macrophages, 30% of the culture medium was replaced by culture conditions described above. From each colony, a cell MAF (macrophage-activating factor). Briefly, to prepare line was expanded as a monolayer: lines were called R lines.
MAF, lymphocytes were isolated from the spleens of These cells were then subjected to a new CZT treatment cycle. syngeneic rats, washed twice, incubated for 4h in a 10%
In the present investigation, the CZT-resistant cells were endofree FCS-HAM medium containing 2 ,ug ml -of identified by the number of CZT treatment cycles they had concanavalin A (Con A), 5 x 106 lymphocytes ml-. After a undergone. At each treatment cycle, part of the cells were 4h incubation at 37°C, 5% CO29 the medium was replaced kept, subcultured and stored in liquid nitrogen.
by the same medium without Con A. After a total period of The same cloning procedure except for the CZT-treatment 48 h, the cells were discarded and the supernatant, designated was used to obtain C lines. The parental line was cloned as MAF, was passed through a 0.22,um Millipore filter and after a 1 h incubation in drug-free medium. From one stored at 4°C until use.
colony, a cell line was obtained and this cycle was repeated.
Macrophages and tumour cells were mixed together in the These reference lines were identified by the number of presence or absence of MAF, with three identical aliquots cloning cycles.
per experiment, for 72h in a 37°C humidified 5% C02/air S4T lines were in vivo resistant cell lines: rats bearing RMS incubator. Then, 0.1 ml (halt) of the supernatant from each 9-4/0 were treated with CZT (10mgkg-1). Local tumours well was collected, mixed with 1 ml of scintillation liquid were dissected when rats were moribund and grafted s.c. into (Aqualuma; Kontron Analytique, Monsigny le Br., France)
a new series of syngenic rats. These rats were treated with and counted in a beta counter. The radioactivity released CZT according to the same protocols. Five in vivo passages represented the radioactive cells killed by macrophages.
and treatments were necessary to obtain S4T lines. These
Lymphocytes comprising natural killer (NK) cells were lines were more tumorigenic and metastatic than RMS 9-4/0.
dissociated from the spleens of healthy rats. After spinning at low speed to eliminate a large number of red blood cells, Evaluation of tumorigenic and metastatic potentials the lymphocytes were counted and adjusted to concentrations of 20, 10, 5 and 2.5 x 106 ml-i of 10% FCS-DME Tumorigenic activity turn + was estimated by the injection medium. Tumour cells were labelled with 200 ,uCi of sodium of 5 x 106 cells s.c. into 8 week old Wistar AG rats. It was 51Cr-chromate (Amersham, UK) added to 2 x 106 tumour concluded that a given line was non tumorigenic (tum-) if cells in a volume of 0.2 ml of complete medium for 2 h at repeated injections did not result in tumours by 12 months 37°C. After extensive washing, labelled tumour cells were after the last tumour cell graft.
suspended at 105 cells ml 1. One hundred ,ul of each suspension were mixed in wells of a 96-well Falcon microselected cells. The R lines were selected after 1 h of contact plate. After 5 h of incubation, 0.1 ml of each suspension was with CZT, immediately followed by cloning in soft agar, measured for radioactivity in a gamma counter.
growth and subsequent passage into liquid medium culture For both cytotoxic assays, total radioactivity was liberated conditions. R lines were defined by their resistance (R) to in the presence of 0. (Table I ).
cpm total labelling -cpm spontaneous release weekly, at the dose of 10mg kg-I (Table II) . As previously described (Poupon et al., 1984; Pauwels et al., 1985) CZT The statistical significance of differences in cloning efficiency enhanced the metastatic potential of RMS 9-4/0 tumours, (CE) or proliferation was analyzed using the Student's t-test. and slowed the growth rate of the primary tumour. This is The median number of lung metastatic nodules was observed when C5 tumour bearing rats were treated. The calculated and the statistical significance was evaluated by growth rate of R-tumours (R3 and R6) was unchanged the non-parametric Wilcoxon test.
under CZT treatment, while their metastases were identically enhanced. In vivo, when RMS 9-4/0, C5, R3 and R6 were Results injected s.c. to induce local tumours, we observed spontaneous dissemination of tumour cells to the lungs . .~~~~~ (Table 11) as well as to the lymph nodes. These lines did not
Tumrigeni obainedfrmetsai chrctrstc of-hetun0 differ significantly from one another and they formed variants obtained from RMS 9-4/0growing tumours.
Subcutaneous injection of 105 viable RMS 9-4/0 cells into From one R6 colony, expanded as a monolayer, we Wistar AG rats was followed by the local growth of a derived four R6 lines from four independent colonies: they tumour, histologically characterized as a differentiated were all tumorigenic and metastatic in syngeneic rats. The rhabdomyosarcoma. After development of the local tumour, four R7 lines derived from independent colonies were found metastases formed in the lymph nodes and then in the lungs, to be non tumorigenic under the same conditions. The same causing the death of animals within 90-100 days. From the observation was made for the C lines after the 7th cycle of RMS 9-4/0 cells, we have obtained two types of in vitro treatment. In all cases, in spite of repeated cell injections, The results suggest the appearance of a newly expressed structure on R9 cells which enables the competent host to and an increase in the number of cells injected to I 0 per rat recognize and reject them. The fact that immunization and several months of observation (12 months), no tumours against R9 cells decreased lung metastatic invasion and appeared. Tumorigenicity seemed to be definitively lost, since stopped liver metastases without affecting primary tumour the subsequent clones R7, R8, R9, C8 and C9 were not growth suggests that identical epitopes are present on these tumorigenic.
CZT-resistant clonogenic cells and on potentially metastatic
We also attempted to induce tumorigenicity by treating R9 cells. tum-cells with CZT before s.c. injection, but had no Immunization of syngeneic immunocompetent rats with success.
C8 cells did not protect them against metastatic invasion of All of the immunodeficient rats, either nude rats on the the lungs after a s.c. graft of RMS 9-4/0 tumour cells (Table  Wistar AG During the selection process, the loss of tumorigenicity by The apparent loss of tumorigenicity by R9 cells and C8 the variants could be related to a higher sensitivity to the cells in immunocompetent animals could be related to their immune system, namely to NK cells or macrophages, acquisition of antigenicity, thus provoking their rejection by activated or not. Indeed, if membrane changes render them normal hosts but not by immunoincompetent Wistar AG highly sensitive to killing, this could explain the results hosts. We have further analysed the immunogenicity of two observed and the absence of tumorigenicity. As shown in selected lines, R9 repeatedly treated with CZT, and C8 not Table IV, the RMS 9-4/0 line is relatively sensitive to NK treated, both selected by the cloning procedure. lysis (29.4% at the 100:1 lymphocyte/tumour cell ratio). In genetically athymic nude mice, R9 and C8 cells gave rise or 25. After 5h of incubation, supernatant alito tumour proliferation in one week, when I x 106 cells were quots were counted in a gamma counter. The injected s.c. When 50 x 106 T enriched spleen cells from nonradioactivity released was proportional to the immunized rats were mixed with R9 or C8 tumour cells, labelled cell lysis. % cytotoxicity was calculated tumour appearance was delayed 6 days, however all the mice for each lymphocyte-to-tumour cell ratio and the eventually developed tumours (Table V) . If T enriched spleen results were analyzed by a computer. The cell cells were obtained from rats immunized against R9 or C8 ratio to % cytotoxicity slope was calculated as .
. well as the regression index which validated the u linear relationship between cytotoxicity and the mice, over the 3 month observation time. Moreover, cell ratio. The % lysis for the ratio 100:1 was immunization against R9 protected against C8 tumour take, deduced from these linear curves.
and vice versa. These results demonstrate that rats developed aRIO clones were derived from the R9 subline. immunity against R9 and C8 tumour cells, that T cells were Nine clones were independently harvested and responsible for their rejection and that C8 and R9 shared expanded as sublines. Each was assayed in the common antigenic structures.
cytotoxicity test. Figure 1 compares the macrophage The procedure of drug contact followed by cloning in semiactivity against R3 tum + and R9 tum -cells. R9 appeared solid agar designated as the Salmon assay (Salmon et al.,
to be strongly resistant to lysis, even when macrophages 1978) has been used by 'many experimenters in order to were activated. Macrophage activation was confirmed by evaluate the sensitivity of stem cells to the cytotoxicity of their increased cytotoxicity against R3 cells. The turnchemotherapeutic drugs. We have used this procedure to phenotype of R9 and C8 cells could not be explained by select cell variants resistant to the nitrosourea, CZT. To enhanced cytotoxicity of these two immune system effectors.
reinforce cell selection, we repeated this procedure nine We have also tried to provoke specific cytotoxicity times. Similar procedures which consist of repeating drug mediated by T lymphocytes from rats immunized against R9 contacts with the tumour cells were often used with different or C8 cells, either as a direct assay or after a four day drugs, leading to the isolation of drug-resistant variants. For stimulation of lymphocytes in the presence of irradiated R9 example, Giavazzi et a!. (1983) , among others, have obtained or C8 tumour cells. The results are not shown since they adriamycin-resistant cells from a murine fibrosarcoma, by revealed no cytotoxicity.
adding progressively increasing doses of adriamycin to the In order to demonstrate the role of immunity in the R9 or cell culture medium. The originality of our study lies in the C8 rejection by immunocompetent Wistar AG rats, we used fact that we have chosen to select clonogenic and chemothe Winn assay.
resistant cells, using a protocol which associated the usual procedure of repeated drug contact with post contact mediated by T cell dependent cytolysis, others inducing a T cloning. This procedure was capable of progressively helper mediated mechanism. Their more surprising obserincreasing the frequency of clonogenic drug-resistant cells vation is that the most malignant line (metastatic) which (selective procedure), or increasing the drug resistance of arose spontaneously under immune pressure, induced an individual clonogenic cells (adaptative mechanism, Laval, immune state in mice, allowing them to reject the graft of 1985). The observation of phenotypic changes in the tumour the parental tumour but not their own graft. This study cells derived from our sarcoma, after treatment by CZT, clearly showed that this highly malignant tumour also could explain two previous observations. Firstly, rats grafted expressed antigenic determinants. The induction of antiwith the RMS 9-4/0 tumour, and subsequently treated by genicity on tumour cells by drugs has already been demon-CZT developed a greater number of lung metastases than strated. Boon, (1985) has shown that N-methyl-N'-nitro-Nnontreated rats. Secondly, in vitro contact of RMS 9-4/0 cells nitrosoguanidine (MNNG) and other mutagens are capable with CZT, increased their cloning efficiency, i.e. induced of inducing a high level of mutants in tumour cells and that some tumour cell to express de novo a clonogenic efficiency.
many of them carry antigenic structures. Some of them are This in vitro procedure for the selection of tumour cell similar to structures present on the parental non-mutated variants, by a selective or adaptive mechanism, could lead to cells, whereas others are specific to each clone. The nature of the isolation of highly metastatic and drug resistant variants. these structures has not been elucidated, but a tissue-specific However, it excludes the selective pressure exerted by the structure determined by the tissue origin of the tumour host.
during embryogenesis is one good candidate (Fidler & We report here that the cloning procedure by itself gave Nicholson 1976; Frost & Kerbel 1983) . Along the same line rise to tum-variants. Two types of tum-variants were of thought, Nardelli has indicated that in murine lymphoma obtained. The R lines after CZT-contact; the C lines without cells repeated treatment with drugs in vitro generated highly drug contact. These two types of clonogenic cells, colony immunogenic sublines (Nardelli et al., 1984) . A similar effect forming cells (CFCs), were shown to be immunogenic in was observed after UV irradiation, which was followed by Wistar AG rats, and tumour cell rejection could be affected cell changes and the appearance of antigenic structures by T cells, as was demonstrated by the transfer of immunity (Kripke et al., 1978 Goodenow et al., 1985) or the abnormality of the balance tumorigenicity in the immunocompetent but not in the between the expression of the two major components, as immunodeficient rat, showing that these cells had acquired related by Katzav et al. (1985) On the other hand, the antigenic state seemed to be stable. common properties which led to their selection. Metastatic The immunogenicity of R9 could be induced by CZTdissemination of tumours involves cellular subpopulations treatment. One elegant explanation, not yet proven, is that which could be more resistant to the chemotherapeutic drugs repeated contact with CZT induces the amplification of than the cell populations of the primary lesion. An antigenic structures which are present on tumour cells alternative could be that the metastatic cells could be more capable of producing in vivo lung or liver metastases. The susceptible to the mutagenic effect of drugs, rendering these high malignancy of tumours could be related to a complete cells subsequently more resistant. The evidence of a common loss of antigenicity. However, Van Waes et al. (1986) antigenicity leads us to believe that the same cell can have demonstrated the maintenance of one antigenic determinant the resistant and metastatic phenotypes and that cloning in expressed on progressively more malignant variants derived semi-solid medium could isolate this cell. from UV-induced tumours. Their data led to the conclusion
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